Taiwan / Germany / France / Japan / United States / China / Lithuania / Israel / / /
Facility
Shanghai Institute of Cell Biology / Institute of Materia Medica / Scale bar / University of Maryland / Xi’an Jiaotong University / /
IndustryTerm
chemical therapy / cancer therapy / e-aminocaproic / cancer treatment / untreated control / analysis software / treatment of lung cancer / mg/ml solution / /
MedicalCondition
inhibited tumor / human colon cancer / Syrigos K. Pancreatic cancer / vivo / human tumor / significantly inhibited tumor / JE / Colorectal cancer / colorectal tumor / metastasis / solid tumors / vivo human colon cancer / colon cancer / genitourinary cancer / human colon tumor / Discussion Colorectal cancer / breast cancer / tumor / Cancer / Tumors / Disease / atherogenesis / estrogen-dependent breast cancer / Clin Exp Metastasis / numerous human tumors / lung cancer / diseases / Folkman J. Tumor / metastases / lovo tumor / lovo human colon cancer / /
MedicalTreatment
chemotherapy / cancer therapy / /
Organization
Institute of Materia Medica / Research and Engineering Center for Natural Medicine / Chinese Academy of Sciences / University of Maryland / Institutional Animal Care and Use Committee / Shanghai Institute of Cell Biology / Xi’an Jiaotong University / School of Pharmacy / National Natural Science Foundation of China / School of Medicine / /
Person
Pierce Biotech / Chen X. Vascular / Chen S. Blueberry / Hong Mao Qi / / /
Position
WB / western blot analysis / *Corresponding author / candidate for colon cancer intervention / Vertino PM / representative / /
A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylation